<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="154617">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01786291</url>
  </required_header>
  <id_info>
    <org_study_id>uyku-cpet-1</org_study_id>
    <nct_id>NCT01786291</nct_id>
  </id_info>
  <brief_title>PAP Therapy Sleep Apnea and Exercise</brief_title>
  <official_title>Effects of Positive Airway Pressure Therapy on Exercise Parameters in Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Gaziantep</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Gaziantep</source>
  <oversight_info>
    <authority>Turkey: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Positive airway pressure (PAP) therapy is generally offered to patients with obstructive
      sleep apnea. The investigators suggest that beneficial effects of PAP therapy is by
      preventing apneas and therefore reducing cardiac and pulmonary morbidities. The
      investigators sought to verify this by assessing cardiac and pulmonary function during
      exercise.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>peak oxygen uptake</measure>
    <time_frame>30-60 days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>ventilatory equivalent for carbon dioxide at anaerobic threshold</measure>
    <time_frame>30-60 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">65</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>CPAP compliant</arm_group_label>
    <description>CPAP (continuous positive airway pressure) compliant patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPAP non-compliant</arm_group_label>
    <description>patients who did not use CPAP therapy</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutive patients newly diasgnosed with obstructive sleep apnea in whom CPAP
        therapy was indicated
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  obstructive sleep apnea diagnosed by polysomnography

          -  CPAP therapy indicated

        Exclusion Criteria:

          -  obstructive or restrictive lung disease

          -  cardiac failure

          -  acute coronary syndrome

          -  inability to cycle
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Meral Uyar, Assoc Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Gaziantep</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nazan Bayram, Assis Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Gaziantep</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Gaziantep, Faculty of Medicine, Dept. of Pulmonary Diseases</name>
      <address>
        <city>Gaziantep</city>
        <zip>27310</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>February 6, 2013</lastchanged_date>
  <firstreceived_date>February 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Gaziantep</investigator_affiliation>
    <investigator_full_name>meral uyar</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>obstructive sleep apnea</keyword>
  <keyword>continuous positive airway pressure</keyword>
  <keyword>cardiopulmonary exercise test</keyword>
  <keyword>VE/VCO2</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
